BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1942901)

  • 1. [Neoplasms following kidney transplantation].
    Beleva B
    Khirurgiia (Sofiia); 1991; 44(1):38-41. PubMed ID: 1942901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant neoplasias in renal transplantation recipients].
    Gómez-Roel X; León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):225-9. PubMed ID: 16524062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Solid tumors after kidney transplantation].
    Moal MC
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S214-7. PubMed ID: 19000890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of cancer after kidney transplant: results from the North Italy transplant program.
    Pedotti P; Cardillo M; Rossini G; Arcuri V; Boschiero L; Caldara R; Cannella G; Dissegna D; Gotti E; Marchini F; Maresca MC; Montagnino G; Montanaro D; Rigotti P; Sandrini S; Taioli E; Scalamogna M
    Transplantation; 2003 Nov; 76(10):1448-51. PubMed ID: 14657684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension following kidney transplantation in patients on conventional immunosuppressive therapy and in those on cyclosporin A].
    Beleva B
    Khirurgiia (Sofiia); 1990; 43(4):43-7. PubMed ID: 2097423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [De novo malignant tumors during drug immunosuppression. The findings following 1245 cadaveric kidney transplants in 1080 patients].
    Walz MK; Albrecht KH; Niebel W; Eigler FW
    Dtsch Med Wochenschr; 1992 Jun; 117(24):927-34. PubMed ID: 1600867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of cancers in immunosuppressed organ transplant recipients.
    Penn I
    Clin Transpl; 1994; ():99-109. PubMed ID: 7547597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
    Hibberd AD; Trevillian PR; Wlodarczyk JH; Kemp DG; Stein AM; Gillies AH; Heer MK; Sheil AG
    Transplantation; 2013 Jan; 95(1):122-7. PubMed ID: 23238532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent contributions to transplantation at the University of Cincinnati.
    Alexander JW; First MR; Hariharan S; Penn I; Schroeder T; Ryckman F; Munda R; Bhat G; Bolce R
    Clin Transpl; 1991; ():159-78. PubMed ID: 1820114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
    Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immunosuppression in malignancies among 351 pediatric renal transplant patients.
    Berardinelli L; Raiteri M; Ghio L; Messa PG; Montagnino G
    Transplant Proc; 2010 May; 42(4):1166-8. PubMed ID: 20534251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy after renal transplantation: incidence and role of type of immunosuppression.
    Tremblay F; Fernandes M; Habbab F; deB Edwardes MD; Loertscher R; Meterissian S
    Ann Surg Oncol; 2002 Oct; 9(8):785-8. PubMed ID: 12374662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension following kidney transplantation in patients on conventional immunosuppressive therapy and in those treated with cyclosporin A].
    Beleva B
    Vutr Boles; 1990; 29(6):47-51. PubMed ID: 2091383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presentation of cancers in recipients of a solid-organ transplant].
    Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
    Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancers after renal transplantation: multicenter experience.
    Harzallah K; Abderrahim E; Chareffedine K; Yeich S; Belhadj R; Skhiri H; Younsi F; Abdallah TB; Abdelletif A; Hachicha J; Hmida J; El May M; Khedr A; Manaa J
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):825-30. PubMed ID: 18711309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
    Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
    Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.